Diagnostic Electrocardiograph Market by Product (Devices, Software & Services), Lead Type (12-lead, 3-lead, 5-lead), End User - Global Forecast 2024-2030
Diagnostic Electrocardiograph Market by Product (Devices, Software & Services), Lead Type (12-lead, 3-lead, 5-lead), End User - Global Forecast 2024-2030
The Diagnostic Electrocardiograph Market size was estimated at USD 11.20 billion in 2023 and expected to reach USD 11.95 billion in 2024, at a CAGR 6.67% to reach USD 17.61 billion by 2030.
A diagnostic electrocardiograph is a non-invasive, essential medical device used in detecting and monitoring heart-related diseases and conditions. Also referred to as an ECG or EKG, this device records the electrical activity of the heart over a period of time through electrodes attached to the skin. Globally, these devices are used in hospitals, clinics, and other healthcare facilities, with increased use in remote patient monitoring, a burgeoning trend in healthcare. Market expansion is propelled by the growing prevalence of cardiovascular ailments, advances in diagnostic technology, and the rise of remote patient monitoring. However, it faces challenges owing to the high cost of electrocardiographs and inadequate reimbursement policies for diagnostic devices. Future growth opportunities for the diagnostic electrocardiograph market lie in the growing adoption of digital health technology with the emerging applications of artificial intelligence and machine learning.
Regional Insights
Blended with innovation and lucrative opportunities, the diagnostic electrocardiograph market in the Americas is expected to grow substantially in the coming years. With the advent of crafted healthcare policies coupled with increased demand for non-invasive techniques and continuous technological advancements in electrocardiographs, this region holds a robust market stronghold. The Electrocardiograph market in the EMEA is gaining momentum, with the region’s increasing demand for advanced diagnostic tools, growing population, and rising health awareness. Europe's strong healthcare sector, paved by advanced disease management protocols, is driving the demand for accurate diagnostic devices including electrocardiographs. The markets in the Middle East and Africa are at a nascent stage but are expected to burgeon, primarily owing to the improving healthcare infrastructure and increased government intervention in healthcare digitalization. The Asia-Pacific (APAC) region, particularly the fast-growing economies of India and China, is creating lucrative opportunities for the diagnostic electrocardiograph market, with their vast patient base and increasing healthcare spending. Furthermore, the increasing prevalence of cardiovascular diseases coupled with the robust investment in advanced medical equipment are distinctive factors that are contributing to this upturn.
Market Insights
Market Dynamics
The market dynamics represent an ever-changing landscape of the Diagnostic Electrocardiograph Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
Rapidly Changing Lifestyles Increase the Incidence of Cardiovascular Diseases Worldwide
Surge in Global Aging Population and Need for Early Diagnosis of Cardiovascular Conditions
Increasing Development and Adoption of Wearable and Wireless Remote Monitoring Devices
Market Restraints
Issues with Unfavourable Reimbursement Policies
Market Opportunities
Emerging Demand from the Developing Economies with Improving Healthcare Infrastructure
Ongoing Advancements in Diagnostics with Increased Investments
Market Challenges
Lack of Skilled Expertise to Operate Advanced ECGs
Market Segmentation Analysis
Product: Growing utilization of software & services or data analysis and accurate interpretation
Lead Type: Growing preference for 12-lead electrocardiograph as it provides the most detailed diagnostics
End-User: Increasing potential of diagnostic electrocardiographs across hospitals & clinics with increased intensive care units and cardiac units
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Diagnostic Electrocardiograph Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Diagnostic Electrocardiograph Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Acorai Wins EUR 2.3 Million Grant to Help Fund Trial for Heart Monitoring Device
Acorai, a cardiology start-up, has secured EUR 2.3 million (USD 2.46m) and an additional EUR 10m (USD 10.70m) investment from the European Innovation Council to advance its non-invasive intracardiac pressure monitoring device. The funds are expected to be utilized for a clinical validation trial and regulatory applications, aiming for FDA submission and clearance by 2025. The innovative device, known as the SAVE sensor system, incorporates seismic, acoustic, visual, and electrical sensors to produce cardiac insights through machine learning software.
AliveCor Collaborates with European Remote Patient Monitoring Company, Offering its 'Virtual Heart Clinic in a Box'
AliveCor, Inc., in collaboration with Luscii, Europe's remote patient monitoring provider, has developed a revolutionary virtual heart clinic in a box for enhanced cardiac care. This innovative solution combines the power of the AliveCor app and Luscii's remote monitoring capabilities to provide an unparalleled patient experience and enable healthcare providers to monitor cardiac patients remotely.
UltraLinQ to Launch New Cardiac Monitoring Product at Arab Health
UltraLinQ Healthcare Solutions, Inc. and LifeSignals are aiming to launch their UltraLinQ Holter Service at Arab Health 2023. This end-to-end system, enabled by LifeSignals’ wireless Holter monitoring ECG analysis and reporting system, offers extended Holter services to patients at home or in the clinic. With a pay-per-use model, the service grants access to a larger patient base without overburdening healthcare professionals.
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Diagnostic Electrocardiograph Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Diagnostic Electrocardiograph Market, highlighting leading vendors and their innovative profiles. These include ACS Diagnostics, AliveCor, Inc., Ambu A/S, Aspel SA, ATsens Co., Ltd., Auxo Medical LLC, Bionet Co., Inc., BPL Medical Technologies Pvt. Ltd., BTL, Cardioline S.p.A., CompuMed, Inc., Custo Med GmbH, Davis Medical Electronics, Inc., Edan Instruments, Inc., Fukuda Denshi Co., Ltd., GE HealthCare Technologies Inc., Hill-Rom, Inc., Innomed Medical Zrt., Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co.,Ltd., Nihon Kohden Corporation, Norav Medical Ltd., OSI Systems, Inc., Schiller AG, Shenzhen Comen Medical Instruments Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Suzuken Co., Ltd., Vectracor, Inc., Viatom Technology Co., Ltd., VYAIRE Medical, Inc., and Zimmer MedizinSysteme GmbH.
Market Segmentation & Coverage
This research report categorizes the Diagnostic Electrocardiograph Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Devices
Event Monitors
Holter Monitors
Implantable Loop Recorders
Mobile Cardiac Telemetry Devices
Resting ECG Devices
Smart ECG Monitors
Stress ECG Devices
Software & Services
Lead Type
12-lead
3-lead
5-lead
6-lead
Single-lead
End User
Ambulatory Surgical Centers
Diagnostic Centers
Hospitals & Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapidly Changing Lifestyles Increase the Incidence of Cardiovascular Diseases Worldwide
5.1.1.2. Surge in Global Aging Population and Need for Early Diagnosis of Cardiovascular Conditions
5.1.1.3. Increasing Development and Adoption of Wearable and Wireless Remote Monitoring Devices
5.1.2. Restraints
5.1.2.1. Issues with Unfavourable Reimbursement Policies
5.1.3. Opportunities
5.1.3.1. Emerging Demand from the Developing Economies with Improving Healthcare Infrastructure
5.1.3.2. Ongoing Advancements in Diagnostics with Increased Investments
5.1.4. Challenges
5.1.4.1. Lack of Skilled Expertise to Operate Advanced ECGs
5.2. Market Segmentation Analysis
5.2.1. Product: Growing utilization of software & services or data analysis and accurate interpretation
5.2.2. Lead Type: Growing preference for 12-lead electrocardiograph as it provides the most detailed diagnostics
5.2.3. End-User: Increasing potential of diagnostic electrocardiographs across hospitals & clinics with increased intensive care units and cardiac units
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Diagnostic Electrocardiograph Market, by Product
6.1. Introduction
6.2. Devices
6.3. Software & Services
7. Diagnostic Electrocardiograph Market, by Lead Type
7.1. Introduction
7.2. 12-lead
7.3. 3-lead
7.4. 5-lead
7.5. 6-lead
7.6. Single-lead
8. Diagnostic Electrocardiograph Market, by End User